Trial Profile
ABT-355 [choline fenofibrate] reverse cholesterol transport (RCT) study
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Sep 2021
Price :
$35
*
At a glance
- Drugs Choline fenofibrate (Primary)
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 14 Oct 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
- 14 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2008 New trial record.